GNH USA

Europe — EMA

Nebilet (Nebivolol)

GNH USA supplies Nebilet (Nebivolol), a beta blocker indicated for hypertension, available for pharmaceutical procurement. Request a quote for global supply.

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebilet, is a beta blocker presented as an oral tablet for oral use. It selectively blocks β1‑adrenergic receptors and also promotes nitric‑oxide mediated vasodilation, contributing to its antihypertensive effect in adult patients with hypertension.

GNH USA supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

What is Nebivolol used for?

Nebilet is a beta‑blocker indicated for the management of elevated blood pressure within the hypertension disease family.

Essential hypertension: reduces systolic and diastolic blood pressure in adults. Primary hypertension: helps achieve target blood pressure levels as part of therapy. High blood pressure: contributes to cardiovascular risk management in hypertensive patients.

What are the side effects of Nebivolol?

Nebilet may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Dizziness - Headache - Fatigue - Bradycardia - Nausea - Flushing

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in susceptible individuals - Allergic reactions such as rash or angioedema - Hepatic dysfunction - Syncope

What precautions apply to Nebivolol?

Before prescribing Nebilet, clinicians should consider several safety aspects.

Blood pressure monitoring: check baseline and periodically during therapy. Heart rate assessment: observe for bradycardia, especially in patients with conduction disorders. Renal impairment: use with caution and adjust if necessary. Hepatic impairment: consider dose reduction or close monitoring. Concomitant beta‑blockers: avoid duplication to prevent excessive β‑blockade. Pregnancy and lactation: safety not established; weigh benefits against potential risks. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

What does Nebivolol interact with?

Nebilet can interact with several drug classes; interactions vary in clinical significance.

Major Interactions (Avoid): - Other β‑blockers: additive β‑blockade may cause severe bradycardia. - Calcium channel blockers (verapamil, diltiazem): increase risk of heart block and bradycardia. - Strong CYP2D6 inhibitors (paroxetine, fluoxetine): raise nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect. - ACE inhibitors or ARBs: monitor blood pressure for additive lowering. - NSAIDs: can attenuate antihypertensive response. - Antidiabetic agents: monitor glucose as beta‑blockade may mask hypoglycemia symptoms.

Frequently asked questions

What is Nebilet used for?+
Nebilet contains nebivolol, a selective β1‑adrenergic blocker that is prescribed to lower high blood pressure in adults diagnosed with hypertension. By reducing vascular resistance and heart rate, it helps achieve target blood pressure levels and lowers the risk of cardiovascular complications.
How does nebivolol work?+
Nebivolol blocks β1‑adrenergic receptors in the heart, decreasing heart rate and contractility. It also stimulates endothelial nitric‑oxide production, causing vasodilation. The combined effect reduces cardiac output and peripheral resistance, leading to a sustained decrease in blood pressure.
What is the usual dose of Nebilet?+
The dose of Nebilet is individualized by the prescribing clinician based on the patient’s blood pressure, age, renal and hepatic function, and concomitant medications. The prescriber determines the appropriate starting dose and any subsequent titration.
Is Nebilet safe in pregnancy or breastfeeding?+
Safety data for nebivolol during pregnancy and lactation are limited. It is classified as a drug with unknown pregnancy category, and the decision to use it should be based on a careful risk‑benefit assessment by the healthcare provider.
How do I order Nebilet from GNH USA?+
To order Nebilet, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Nebilet compare with other beta blockers?+
Nebilet (nebivolol) is a third‑generation β1‑selective blocker with additional nitric‑oxide‑mediated vasodilatory activity, which may result in fewer metabolic side effects compared with older non‑selective beta blockers. Its profile is often considered advantageous for patients who need both heart‑rate control and improved endothelial function.
How should Nebilet be stored and handled?+
Nebilet should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.
How is Nebilet administered?+
Nebilet is taken orally, usually once daily, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks to watch for while taking Nebilet?+
Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare cases of hepatic dysfunction or allergic reactions. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling, or difficulty breathing.
Who should not use Nebilet?+
Nebilet is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe chronic obstructive pulmonary disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Berlin-Chemie Menarini Hrvatska D.O.O.
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA